Literature DB >> 22072786

Human pathogens and the host cell SUMOylation system.

Peter Wimmer1, Sabrina Schreiner, Thomas Dobner.   

Abstract

Since posttranslational modification (PTM) by the small ubiquitin-related modifiers (SUMOs) was discovered over a decade ago, a huge number of cellular proteins have been found to be reversibly modified, resulting in alteration of differential cellular pathways. Although the molecular consequences of SUMO attachment are difficult to predict, the underlying principle of SUMOylation is altering inter- and/or intramolecular interactions of the modified substrate, changing localization, stability, and/or activity. Unsurprisingly, many different pathogens have evolved to exploit the cellular SUMO modification system due to its functional flexibility and far-reaching functional downstream consequences. Although the extensive knowledge gained so far is impressive, a definitive conclusion about the role of SUMO modification during virus infection in general remains elusive and is still restricted to a few, yet promising concepts. Based on the available data, this review aims, first, to provide a detailed overview of the current state of knowledge and, second, to evaluate the currently known common principles/molecular mechanisms of how human pathogenic microbes, especially viruses and their regulatory proteins, exploit the host cell SUMO modification system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072786      PMCID: PMC3255802          DOI: 10.1128/JVI.06227-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  202 in total

1.  Yersinia lead SUMO attack.

Authors:  G R Cornelis; G Denecker
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

Review 2.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

3.  Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins.

Authors:  C L Malone; D H Vesole; M F Stinski
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification.

Authors:  Yoshihiro Izumiya; Thomas J Ellison; Edward T H Yeh; Jae U Jung; Paul A Luciw; Hsing-Jien Kung
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Influenza A virus interacts extensively with the cellular SUMOylation system during infection.

Authors:  Sangita Pal; Andres Santos; Juan M Rosas; Joshua Ortiz-Guzman; Germán Rosas-Acosta
Journal:  Virus Res       Date:  2011-03-03       Impact factor: 3.303

6.  Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.

Authors:  Andrew Yueh; Juliana Leung; Subarna Bhattacharyya; Lucy A Perrone; Kenia de los Santos; Szy-Yuan Pu; Stephen P Goff
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Polymorphisms in the UBC9 and PIAS3 genes of the SUMO-conjugating system and breast cancer risk.

Authors:  Thomas Dünnebier; Justo Lorenzo Bermejo; Susanne Haas; Hans-Peter Fischer; Christiane B Pierl; Christina Justenhoven; Hiltrud Brauch; Christian Baisch; Michael Gilbert; Volker Harth; Anne Spickenheuer; Sylvia Rabstein; Beate Pesch; Thomas Brüning; Yon-Dschun Ko; Ute Hamann
Journal:  Breast Cancer Res Treat       Date:  2009-09-17       Impact factor: 4.872

8.  Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).

Authors:  Yu-Chieh Wu; Ashley A Roark; Xue-Lin Bian; Van G Wilson
Journal:  Virology       Date:  2008-07-11       Impact factor: 3.616

9.  Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific.

Authors:  Pei-Ching Chang; Yoshihiro Izumiya; Chun-Yi Wu; Latricia D Fitzgerald; Mel Campbell; Thomas J Ellison; Kit S Lam; Paul A Luciw; Hsing-Jien Kung
Journal:  J Biol Chem       Date:  2009-12-24       Impact factor: 5.157

10.  The vaccinia virus E3L protein interacts with SUMO-1 and ribosomal protein L23a in a yeast two hybrid assay.

Authors:  S Rogan; S Heaphy
Journal:  Virus Genes       Date:  2000-10       Impact factor: 2.198

View more
  69 in total

1.  SUMO Modification Stabilizes Enterovirus 71 Polymerase 3D To Facilitate Viral Replication.

Authors:  Yan Liu; Zhenhua Zheng; Bo Shu; Jin Meng; Yuan Zhang; Caishang Zheng; Xianliang Ke; Peng Gong; Qinxue Hu; Hanzhong Wang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

2.  Binding properties of SUMO-interacting motifs (SIMs) in yeast.

Authors:  Christophe Jardin; Anselm H C Horn; Heinrich Sticht
Journal:  J Mol Model       Date:  2015-02-19       Impact factor: 1.810

3.  Quantitative proteomics reveals factors regulating RNA biology as dynamic targets of stress-induced SUMOylation in Arabidopsis.

Authors:  Marcus J Miller; Mark Scalf; Thérèse C Rytz; Shane L Hubler; Lloyd M Smith; Richard D Vierstra
Journal:  Mol Cell Proteomics       Date:  2012-11-29       Impact factor: 5.911

4.  Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.

Authors:  Francis Impens; Lilliana Radoshevich; Pascale Cossart; David Ribet
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-11       Impact factor: 11.205

5.  Sp100 isoform-specific regulation of human adenovirus 5 gene expression.

Authors:  Julia Berscheminski; Peter Wimmer; Juliane Brun; Wing Hang Ip; Peter Groitl; Tim Horlacher; Ellis Jaffray; Ron T Hay; Thomas Dobner; Sabrina Schreiner
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

6.  Adenovirus regulates sumoylation of Mre11-Rad50-Nbs1 components through a paralog-specific mechanism.

Authors:  Sook-Young Sohn; Patrick Hearing
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

7.  Human Adenovirus Core Protein V Is Targeted by the Host SUMOylation Machinery To Limit Essential Viral Functions.

Authors:  Nora Freudenberger; Tina Meyer; Peter Groitl; Thomas Dobner; Sabrina Schreiner
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

8.  Exploiting Ubiquitin Ligases for Induced Target Degradation as an Antiviral Strategy.

Authors:  Rati Verma
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Posttranslational modification of vesicular stomatitis virus glycoprotein, but not JNK inhibition, is the antiviral mechanism of SP600125.

Authors:  Sabrina Marozin; Jennifer Altomonte; Sibylle Apfel; Phat X Dinh; Enrico N De Toni; Antonia Rizzani; Andreas Nüssler; Nobuyuki Kato; Roland M Schmid; Asit K Pattnaik; Oliver Ebert
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

10.  Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.

Authors:  Vasvi Tripathi; Kiran Sankar Chatterjee; Ranabir Das
Journal:  J Biol Chem       Date:  2019-08-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.